Dr. Wald is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
11100 Euclid Avenue
Cleveland, OH 44106Phone+1 216-844-3616
Education & Training
- Case Western Reserve University/University Hospitals Cleveland Medical CenterResidency, Pathology-Anatomic and Clinical, 2005 - 2008
- Case Western Reserve University School of MedicineClass of 2005
Certifications & Licensure
- OH State Medical License 2007 - 2025
- American Board of Pathology Pathology - Clinical
Publications & Presentations
PubMed
- Arsenic trioxide versus Realgar-Indigo naturalis formula in non-high-risk acute promyelocytic leukemia: a multicenter, randomized trial.Shu Chen, Weiwei Qin, Xiaohong Lu, Li Liu, Yinsuo Zheng
Haematologica. 2024-11-07 - An Extended Flow Cytometry Evaluation of ex Vivo Expanded NK Cells Using K562.Clone1, a Feeder Cell Line Manufactured in Brazil.Caroline Mitiká Watanabe, Caroline Ishihama Suzuki, Alessandro Marins Dos Santos, Thiago Pinheiro Arrais Aloia, Grace Lee
Transplantation and Cellular Therapy. 2024-11-01 - Flow cytometry of DNMT1 as a biomarker of hypomethylating therapies.Philip G Woost, Basem M William, Brenda W Cooper, Masumi Ueda Oshima, Folashade Otegbeye
Cytometry. Part B, Clinical Cytometry. 2024-01-01
Abstracts/Posters
- Phase 1 Study of on Site Manufactured Anti-CD19 CAR-T Cells: Responses in Subjects with Rapidly Progressive Refractory LymphomasDavid Wald, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
- Small Molecule Screening Identifies Rho-Associate Protein Kinase (ROCK) As a Regulator of NK Cell Cytotoxicity Against CancerDavid Wald, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
Press Mentions
- New Trials Following Successful Approach to Producing and Using Anti-CD19 CAR T Cells Against B-cell MalignanciesDecember 21st, 2021
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: